Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S C Khani

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Molecular Vision|January 5, 2000
11-cis retinol dehydrogenase mutations as a major cause of the congenital night-blindness disorder known as fundus albipunctatusF Gonzalez-Fernandez, D Kurz, Y Bao, et al.
Gene Therapy|August 28, 2009
Gene therapy with a promoter targeting both rods and cones rescues retinal degeneration caused by AIPL1 mutationsX Sun, B Pawlyk, X Xu, et al.
Gene Therapy|November 15, 2024
Retraction Note: Gene therapy with a promoter targeting both rods and cones rescues retinal degeneration caused by AIPL1 mutationsX Sun, B Pawlyk, X Xu, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Molecular Vision|January 5, 2000
11-cis retinol dehydrogenase mutations as a major cause of the congenital night-blindness disorder known as fundus albipunctatusF Gonzalez-Fernandez, D Kurz, Y Bao, et al.
Gene Therapy|August 28, 2009
Gene therapy with a promoter targeting both rods and cones rescues retinal degeneration caused by AIPL1 mutationsX Sun, B Pawlyk, X Xu, et al.
Gene Therapy|November 15, 2024
Retraction Note: Gene therapy with a promoter targeting both rods and cones rescues retinal degeneration caused by AIPL1 mutationsX Sun, B Pawlyk, X Xu, et al.
Pageof 2